The EU approved Sanofi’s Teizeild to delay type 1 diabetes in high-risk patients, based on strong trial results.

Australian scientists developed a targeted immunotherapy for myelofibrosis, a rare blood cancer, based on specific gene mutations.

Scientists created sharper, multicolor gamma-ray beams using shaped laser pulses, enabling compact, tunable sources for medical and industrial use.

Afghanistan to build $8.7M medical university in Khost with hospital and five faculties.

PromiCell's CAR T therapy for prostate cancer shows early promise in first human trial, to be presented Jan. 12, 2025.

A Scottish woman with rare blindness reports remarkable sight recovery after experimental UK treatment.

Alembic gets FDA tentative approval for generic Bosutinib to treat certain leukemia patients.

Abivax shares jumped 22% on Jan. 12, 2026, on takeover rumors after Eli Lilly considered a 15 billion euro bid.

A Canadian study developed a blood test that detects Crohn’s disease up to 2.5 years before symptoms in high-risk individuals by spotting antibodies to a bacterial protein.

Eisai acquires global rights to lung cancer drug taletrectinib outside U.S., China, and Japan, with a $60M upfront payment and potential milestones.